Highlights of PBTI Coimbra Conference on PRT of Plasma & Current Opinions on Pathogen Reduction Treatment of Blood Components

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Gracinda de Sousa, Jerard Seghatchian

Abstract

Two experts from Octapharma and from Cerus addressed, in very concise ways, the concerns about non-viral inactivated FFP and how they managed to obtain highest standard of safety margin for pathogen reduction treatment [PRT] of plasma. The session was moderated by Portuguese Institute of Blood and Transplantation (PIBT) consultant advisor [Jerard Seghatchian] with long standing familiarity and international recognition in PR technologies for plasma, platelets and WB/red cells. The focus of conference was mainly on the criteria of acceptability of PRT-FFP; added values of having diversity in choice without fears of liability, as both of PRT technologies provide an excellent safeguard margins, for more than a decade of usage. In most European countries, it is believed that patients' safety come first followed by the safe usage initiatives, in particular using locally available products. Portugal is finally going forward with the implementation PRT plasma using its own FFP for their clinical use. The round table Q&A session focused on the impacts of the additional processing, which is still continuously improving, on the residual/emerging pathogen infectivity; eliminating the clinical impacts of donors viable leukocytes; the degre...Continue Reading

References

Aug 6, 2000·British Journal of Haematology·D Pamphilon
Feb 16, 2002·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·J Seghatchian, J P Allain
Nov 18, 2006·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Jerard Seghatchian, Gracinda de Sousa
Nov 16, 2010·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Tor HervigTorunn Oveland Apelseth
Jul 23, 2011·Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie·Jerard SeghatchianStefan Reichenberg
Nov 9, 2012·Vox Sanguinis·C V Prowse
Aug 22, 2013·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Jerard Seghatchian, Jeffrey S Putter
Jan 27, 2015·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Vishal SalunkheLaura Gutiérrez

❮ Previous
Next ❯

Citations

Nov 26, 2015·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Philippe PonceletFrançois Mullier
Aug 16, 2016·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Jerard Seghatchian, Jean Amiral
Aug 1, 2016·La Presse médicale·Olivier GarraudBruno Pozzetto
Mar 10, 2015·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Jerard Seghatchian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Johannes Irsch, Jerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Andrea Neisser-Svae, Jerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Jerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Jerard Seghatchian, Jeffrey S Putter
© 2021 Meta ULC. All rights reserved